Ming‐Chieh Kuo
Papers
2
Total Citations
20
H-Index
2
About
Dr. Ming-Chieh Kuo is a translational cancer immunologist whose research centers on the interplay between natural killer (NK) cells and prostate cancer (PCa) progression. Her work has fundamentally advanced our understanding of how the immune system’s innate surveillance mechanisms are modulated in the tumor microenvironment. In a landmark 2020 study (14 citations), Dr. Kuo demonstrated that lower postoperative NK cell activity is significantly associated with positive surgical margins after radical prostatectomy, establishing NK cell function as a critical prognostic indicator. Building on this, her 2023 investigation (6 citations) revealed that NKG2A receptor expression and circulating extracellular vesicles are key regulators of NK cell activity following prostatectomy, elucidating a novel mechanism by which tumors evade immune detection. By linking peripheral blood EV profiles to NK cell dysfunction, Dr. Kuo’s work has opened new avenues for liquid biopsy-based immune monitoring and potential immunotherapeutic strategies in prostate cancer. Her research bridges fundamental immunology with clinical oncology, providing actionable insights for postoperative risk stratification. With a focused trajectory on NK cell biology in urologic malignancies, Dr. Kuo continues to shape the frontier of cancer immunology, offering hope for improved outcomes through immune-based interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2